Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Am J Infect Control ; 52(8): 934-940, 2024 08.
Artigo em Inglês | MEDLINE | ID: mdl-38460730

RESUMO

BACKGROUND: To evaluate the economic loss of hospital-acquired infections (HAIs) among tumor patients so as to help policymakers to allocate health care resources and address the issue. METHODS: We conducted a retrospective, 1:1 matched case-control study in a large region cancer hospital between January 1 and December 31, 2022. The economic burden was estimated as the median of the 1:1 pair differences of various hospitalization fees and hospital length of stay (LOS). RESULTS: In this study of 329 matched pairs, the patients with HAIs incurred higher hospitalization cost (ie, $16,927) and experienced longer hospital LOS (ie, 22 days), compared to the non-HAI groups. The extra hospitalization cost and the prolonged hospital LOS caused by HAIs were $4,919 and 9 days, respectively. Accordingly, the direct nonmedical economic loss attributable to HAI was approximately $478 to 835 per case. Furthermore, the increment of hospitalization costs varied by sites of infection, types of tumors, and stratum of age. CONCLUSIONS: HAIs lead to the increment of direct economic burden and hospital LOS in tumor patients. Our findings highlight the importance of implementing effective infection control measures in hospitals to reduce the financial burden on tumor patients.


Assuntos
Infecção Hospitalar , Neoplasias , Humanos , Infecção Hospitalar/economia , Infecção Hospitalar/epidemiologia , China/epidemiologia , Masculino , Feminino , Estudos Retrospectivos , Pessoa de Meia-Idade , Neoplasias/economia , Neoplasias/epidemiologia , Estudos de Casos e Controles , Idoso , Adulto , Efeitos Psicossociais da Doença , Tempo de Internação/economia , Tempo de Internação/estatística & dados numéricos , Hospitalização/economia , Hospitalização/estatística & dados numéricos , Institutos de Câncer/economia , Idoso de 80 Anos ou mais , Custos de Cuidados de Saúde/estatística & dados numéricos
2.
Environ Res ; 212(Pt C): 113427, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35561826

RESUMO

Although environmental tobacco smoke (ETS) exposure is considered to be a severe public health problem and a modifiable risk factor for preterm birth (PTB), we still lack a comprehensive understanding of the PTB risk associated with trimester-specific prenatal ETS exposure. This study aimed to examine the accumulation of risk across trimester ETS exposure and the critical window of the association between maternal ETS exposure during pregnancy and PTB. A total of 63,038 mother-child pairs were involved in the analysis of the 2017 survey of Longhua Child Cohort Study. Information about socio-demographic characteristics, prenatal ETS exposure, and birth outcomes were collected using a self-report questionnaire. A series of logistic regression models were employed to assess the associations between prenatal ETS exposure and PTB. We found that maternal ETS exposure during pregnancy significantly increased the risk of PTB and this association increased with both the average level of daily ETS exposure and the number of trimesters of ETS exposure. Moreover, mothers who were initially exposed to ETS in the 1st trimester of pregnancy had significant higher risk of PTB (OR = 1.34, 95% CI: 1.25-1.44). Furthermore, mothers exposed to ETS in the 1st trimester only (OR = 1.26, 95%CI: 1.04-1.50), in both 1st and 2nd trimester (OR = 1.35, 95%CI: 1.08-1.67) and throughout pregnancy (OR = 1.35, 95%CI: 1.24-1.46) experienced a significantly high risk of PTB. Prenatal maternal ETS exposure during only the 2nd trimester also resulted in a high risk of PTB with marginal significance (OR = 1.33, 95% CI:0.78-2.13). To conclude, the 1st and early 2nd trimester might be the critical window for prenatal ETS exposure causing PTB.


Assuntos
Nascimento Prematuro , Efeitos Tardios da Exposição Pré-Natal , Poluição por Fumaça de Tabaco , Estudos de Coortes , Exposição Ambiental , Feminino , Humanos , Recém-Nascido , Exposição Materna/efeitos adversos , Gravidez , Trimestres da Gravidez , Nascimento Prematuro/epidemiologia , Nascimento Prematuro/etiologia , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Poluição por Fumaça de Tabaco/efeitos adversos
3.
Hua Xi Kou Qiang Yi Xue Za Zhi ; 38(6): 704-707, 2020 Dec 01.
Artigo em Chinês | MEDLINE | ID: mdl-33377351

RESUMO

Mesenchymal stem cells (MSCs), which have the potential of self-replication and differentiation, are a very valuable cell source for stem cell-based medical therapy. Their application has opened up a new way for disease research. Although MSCs can maintain cell stemness through self-renewal, with the prolongation of cell passage and culture time, the stemness of MSCs gradually decays, and the cell aging and differentiation potential decreases gradually. Autophagy is a highly conserved cytological process that degrades the modified, excess, and deleterious cytoplasmic components in autophagosomes, which are then degraded by fusion with lysosomes. As the main intracellular degradation and recycling pathway, autophagy plays an active role in maintaining cell homeostasis, self-renewal and pluripotency. In this paper, the role of autophagy in self-renewal and maintenance of multidirectional differentiation potential of MSCs was reviewed, which laid a theoretical foundation and practical basis for the research and application of MSCs.


Assuntos
Células-Tronco Mesenquimais , Autofagia , Diferenciação Celular , Homeostase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA